Capnia announces $10 million stock purchase agreement with Aspire Capital
Capnia announced a common stock purchase agreement with Aspire Capital Fund. Capnia has the right to sell up to $10 million in value of its common stock to Aspire Capital over a two-year period. The agreement provides Capnia with important capital to fund development of its therapeutics pipeline. July 27, 2015